Sökning: WFRF:(van Diepen Sean)
> (2013)
> Armstrong Paul W. >
Prognostic relevanc...
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI : An APEX AMI substudy
-
van Diepen, Sean (författare)
-
Newby, L. Kristin (författare)
-
Lopes, Renato D. (författare)
-
visa fler...
-
Stebbins, Amanda (författare)
-
Hasselblad, Vic (författare)
-
- James, Stefan (författare)
- Uppsala universitet,Kardiologi
-
Roe, Matthew T. (författare)
-
Ezekowitz, Justin A. (författare)
-
Moliterno, David J. (författare)
-
Neumann, Franz-Josef (författare)
-
Reist, Craig (författare)
-
Mahaffey, Kenneth W. (författare)
-
Hochman, Judith S. (författare)
-
Hamm, Christian W. (författare)
-
Armstrong, Paul W. (författare)
-
Granger, Christopher B. (författare)
-
Theroux, Pierre (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2013
- 2013
- Engelska.
-
Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 168:3, s. 2127-2133
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Plaque rupture, acute ischemia, and necrosis in acute coronary syndromes are accompanied by concurrent pro-and anti-inflammatory cascades. Whether STEMI clinical prediction models can be improved with the addition of baseline inflammatory biomarkers remains unknown. Methods: In an APEX-AMI trial substudy, 772 patients had a panel of 9 inflammatory serum biomarkers, high sensitivity C reactive protein (hsCRP), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) measured at baseline after randomization. Baseline biomarkers were incorporated into a clinical prediction model for a composite of 90-day death, shock, or heart failure. Incremental prognostic value was assessed using Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI). Results: Individually, several biomarkers were independent predictors of clinical outcome: hsCRP (hazard ratio [HR] 1.12; 95% confidence interval [CI], 1.03-1.21; p=0.007, per doubling), NT-proBNP (HR 1.14; 95% CI, 1.06-1.23; p<0.001, per doubling), interleukin (IL)-6 (HR 1.26; 95% CI, 1.12-1.41; p<0.001, per doubling), and inducible protein-10 (IP-10) (HR 0.86; 95% CI, 0.76-0.98; p<0.025, per doubling). The addition of baseline NT-proBNP (NRI 8.6%, p=0.028; IDI 0.030, p<0.001) and IL-6 (NRI 8.8%, p=0.012; IDI 0.036, p<0.001) improved the clinical risk prediction model and the addition of hsCRP (NRI 6.5%, p=0.069; IDI 0.018, p=0.004) yielded minimal improvement. After incorporating NT-proBNP into the model, the remaining biomarkers added little additional predictive value. Conclusions: Multiple inflammatory biomarkers independently predicted 90-day death, shock or heart failure; however, they added little value to a clinical prediction model that included NT-proBNP. Future studies of inflammatory biomarkers in STEMI should report incremental value in a prediction model that includes NT-proBNP.
Nyckelord
- Myocardial infarction
- Inflammation
- Prediction models
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
van Diepen, Sean
-
Newby, L. Kristi ...
-
Lopes, Renato D.
-
Stebbins, Amanda
-
Hasselblad, Vic
-
James, Stefan
-
visa fler...
-
Roe, Matthew T.
-
Ezekowitz, Justi ...
-
Moliterno, David ...
-
Neumann, Franz-J ...
-
Reist, Craig
-
Mahaffey, Kennet ...
-
Hochman, Judith ...
-
Hamm, Christian ...
-
Armstrong, Paul ...
-
Granger, Christo ...
-
Theroux, Pierre
-
visa färre...
- Artiklar i publikationen
-
International Jo ...
- Av lärosätet
-
Uppsala universitet